Is amiodarone (generic name) associated with nausea and vomiting?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Yes, amiodarone is known for causing nausea and vomiting as side effects, as evidenced by the most recent and highest quality study available 1. These gastrointestinal symptoms are relatively common in patients taking this antiarrhythmic medication, particularly during the initial loading phase or when higher doses are used. According to the study published in the European Heart Journal in 2022 1, amiodarone can cause gastrointestinal side effects, including nausea, emesis, and constipation. The study also recommends monitoring the ECG and BP, and suggests that maintenance should be max 200 mg/day to minimize these side effects. Taking amiodarone with food may help reduce these side effects, and if they become severe or persistent, patients should consult their healthcare provider for dosage adjustments or alternative medications 1. Some key points to consider when managing nausea and vomiting in patients taking amiodarone include:

  • Assessing for other causes of nausea, such as constipation or CNS pathology
  • Considering alternative therapies that target different mechanisms of action, such as serotonin receptor antagonists or corticosteroids
  • Educating patients on the potential side effects of amiodarone and the importance of reporting any unusual symptoms. It's worth noting that while other studies, such as those published in 2019 1, discuss the management of nausea and vomiting in different contexts, the most relevant and recent evidence for amiodarone-specific side effects is found in the 2022 study 1.

From the FDA Drug Label

The most common adverse effects leading to discontinuation of amiodarone HCl injection therapy were hypotension (1.6%), asystole/cardiac arrest/EMD (1.2%), VT (1. 1%), and cardiogenic shock (1%). The following table lists the most common (incidence ≥ 2%) treatment-emergent adverse events during amiodarone HCl injection therapy considered at least possibly drug-related... Other treatment-emergent possibly drug-related adverse events reported in less than 2% of patients receiving amiodarone HCl injection in controlled and uncontrolled studies included the following: ... vomiting (sometimes fatal)

  • Nausea is not explicitly mentioned in the drug label as an adverse effect.
  • Vomiting is mentioned as a possible drug-related adverse event, but with an incidence of less than 2%. Amiodarone is known for causing vomiting, but there is no direct information about nausea.

From the Research

Side Effects of Amiodarone

  • Amiodarone has several side effects, including thyroid abnormalities, pulmonary fibrosis, and transaminitis, for which routine monitoring is recommended 2.
  • The drug also interacts with several medications, such as warfarin, simvastatin, and atorvastatin, and many HIV antiretroviral medications 2.
  • However, nausea and vomiting are not explicitly mentioned as side effects of amiodarone in the provided studies.

Gastrointestinal Side Effects

  • None of the studies provided (3,2,4,5,6) mention nausea and vomiting as common side effects of amiodarone.
  • The studies focus on the effectiveness of amiodarone in managing atrial fibrillation, its interactions with other medications, and its comparison with other antiarrhythmic drugs.

Conclusion on Nausea and Vomiting

  • Based on the provided studies, there is no evidence to suggest that amiodarone is known for causing nausea and vomiting 3, 2, 4, 5, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Amiodarone: A Comprehensive Guide for Clinicians.

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2020

Research

Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.